CBT
Get informed when a big investor buys or sells
+ FollowUndervalued by 207.1% based on the discounted cash flow analysis.
| Market cap | $4.21 Billion |
|---|---|
| Enterprise Value | $5.25 Billion |
| Dividend Yield | $1.84 (2.26%) |
| Earnings per Share | $6.07 |
| Beta | 0.84 |
| Outstanding Shares | 51,600,000 |
| P/E Ratio | 22.57 |
|---|---|
| PEG | -24 |
| Price to Sales | 1.16 |
| Price to Book Ratio | 2.47 |
| Enterprise Value to Revenue | 1.44 |
| Enterprise Value to EBIT | 10.35 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.81 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0698▼ 57.80% |
|---|---|
| Total Calls | 220,700▲ 421.75% |
| Total Puts | 15,400▼ 43.80% |
Holdings and activity of institutional investors.
| Ownership % | 116.20%▲ 17.68% |
|---|---|
| Total Invested | $5.00B▲ 29.56% |
| Investors Holding | 396▲ 18.00% |
No data